Bioink Market Size

Bioink Market Size

Bioink Market size was valued at USD 159.5 Million in 2023 and is anticipated to grow at a CAGR of 18.1% from 2024 to 2032, driven by factors such as the increase in application of bioink in biomedical research and therapy, and rising incidence of chronic disease and organ failure has heightened the need for innovative medical solutions, including bio-printed tissues and organs that fuels the market demand.

To get key market trends

  Download Free Sample

Moreover, the increase in advancement in bioprinting technology owing to increase in the number of collaboration and partnership between pharmaceutical companies and research institutes is expected to boost the market growth. For instance, in July 2023, CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, announced the launch of its new line of bioinks for 3D bioprinting. The new bioinks are designed to be biocompatible and versatile, making them ideal for a wide range of applications, including 3D biological model construction and cultivation, tissue engineering, and drug delivery.

A bioink is any natural or synthetic polymer which has been selected for its biocompatible components and favourable rheological properties. It will typically support living cells, and its characteristics aids cell adhesion, cell proliferation and cell differentiation during maturation. It is used to produce engineered (artificial) live tissue using 3D printing technology. It can be composed only of cells, but in most cases, an additional carrier material that envelops the cells is also added. This carrier material is usually a biopolymer gel, which acts as a 3D molecular scaffold. Cells attach to this gel, and this enables them to spread, grow and proliferate.